{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:38:09Z","timestamp":1761061089468,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12350-020-02272-4","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T13:02:31Z","timestamp":1594904551000},"page":"97-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?"],"prefix":"10.1016","volume":"29","author":[{"given":"Richard C.","family":"Brunken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02272-4_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12350-018-1438-x","article-title":"Optimizing cardiac sarcoid imaging with FDG PET: Lessons from studies of physiologic regulation of myocardial fuel substrate utilization (editorial)","volume":"27","author":"Schwartz","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib3","article-title":"Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis","author":"Miller","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12149-018-1250-3","article-title":"Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis","volume":"32","author":"Lebasnier","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-020-02272-4_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18F-flurodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02272-4_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s12350-014-9921-5","article-title":"Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"21","author":"Waller","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib8","article-title":"The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis","author":"Flores","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol Imag"},{"key":"10.1007\/s12350-020-02272-4_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-018-4195-9","article-title":"Use of 18F-FDG PET\/CT texture analysis to diagnose cardiac sarcoidosis","volume":"46","author":"Manabe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-020-02272-4_bib11","article-title":"Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis","author":"Kim","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-020-02272-4_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"J Am Coll Cardiol Imaging"},{"key":"10.1007\/s12350-020-02272-4_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1007\/s12350-020-02272-4_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-020-02272-4_bib16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2967\/jnumed.119.237446","article-title":"Does 2-FDG PET accurately reflect quantitative in vivo glucose utilization?","volume":"61","author":"Barrio","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-020-02272-4_bib17","first-page":"131","article-title":"Glucose transporters in the mammalian blood cells","volume":"116","author":"Vrhovac","year":"2014","journal-title":"Periodicum Biologorum"},{"key":"10.1007\/s12350-020-02272-4_bib18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02272-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123002179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:10:09Z","timestamp":1761027009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123002179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1071358123002179"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02272-4","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02272-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}